Linear regression models were used for association of phenotypes (z-score residuals of insulin secretion and action traits) with genotypes coded additively. Discovery (stage 1) GWAS analyses were carried out using a statistical tool that was able to account for genotype uncertainty, SNPTEST [29] (link), or by using allele dosages in the linear regression model in MACH2QTL [30] (link), [31] (link), probABEL [32] , corrected for residual inflation of the test statistics using the genomic control method [33] (link). The meta-analyses of effect sizes were performed with the fixed-effect inverse-variance method using GWAMA [34] (link). The GC correction was applied only once to cohort-specific results before including them into the meta-analyses. Sex-differentiated analyses were performed using GWAMA, with an assumed heterogeneity p-value of <0.05. Effect sizes for glucose levels were estimated using a fixed-effect model using the metaphor package for R version 2.14.2 (http://www.r-project.org/).
Free full text: Click here